Anti-Active Rab3 Mouse Monoclonal Antibody-抗體-抗體-生物在線
武漢紐斯特生物技術有限公司
Anti-Active Rab3 Mouse Monoclonal Antibody

Anti-Active Rab3 Mouse Monoclonal Antibody

商家詢價

產品名稱: Anti-Active Rab3 Mouse Monoclonal Antibody

英文名稱: Anti-Active Rab3 Mouse Monoclonal Antibody

產品編號: 26920

產品價格: null

產品產地: 美國

品牌商標: NewEastbio

更新時間: null

使用范圍: IP, IHC

武漢紐斯特生物技術有限公司
  • 聯系人 :
  • 地址 : 武漢市東湖新技術開發區光谷生物城B3-3棟2-3樓
  • 郵編 : 430074
  • 所在區域 : 湖北
  • 電話 : 186****7297 點擊查看
  • 傳真 : 點擊查看
  • 郵箱 : neweast3@126.com

Catalog Number:??26920
Gene Symbol:?? RAB3
Description: ??Anti-Active Rab3 Mouse Monoclonal Antibody
Background: ??Rab3 is a member of the Rab-family GTPases and is specifically targeted to synaptic vesicles.
Immunogen: ??Recombinant full length protein of active Rab3A
Applications: ??IP, IHC, IF
Recommended Dilutions: ??
1 μg for ~2 mg total cellular proteins for IP
1:100 dilution for IHC, IF
Concentration: ??1 mg/ml
Host: ??mouse
Format: ??Liquid
Clonality: ??Monoclonal
Isotype: ??IgG
Purity: ??Purified from ascites
Storage buffer:
Preservative:??no
Constituents:??PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 50% glycerol
Species Reactivity:??Anti-active Rab3 antibody recognizes active Rab3 proteins of vertebrates.
Storage Conditions:??Store at -20°C. Avoid freeze / thaw cycles
?
Immunoprecipitation/Western blot:??
Rab3 activation assay. Purified full-length Rab3A proteins were immunoprecipitated after treated with GDP (lane 1) orGTPγS (lane 2). Immunoprecipitation was done with the anti-active Rab3 monoclonal antibody (Cat. No. 26920). Immunoblot was with an anti-Rab3A polyclonal antibody (Cat. No. 21041).
?
Publications:
1.??VASP promotes TGF-β activation of hepatic stellate cells by regulating Rab11 dependent plasma membrane targeting of TGF-β receptors
????Hepatology Volume 61, Issue 1, pages 361–374, January 2015
2.??Rab5 Activity Regulates GLUT4 Sorting into Insulin-Responsive and Non-Insulin-Responsive Endosomal Compartments: A Potential Mechanism for Development of Insulin Resistance
????Endocrinology. 2014 Sep;155(9):3315-28

?